BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32571446)

  • 1. Usefulness of N-terminal pro-B-type natriuretic peptide (NT-ProBNP) as a marker for cardiotoxicity and comparison with echocardiography in paediatric carbon monoxide poisoning.
    Turan C; Dogan E; Yurtseven A; Saz EU
    Cardiol Young; 2020 Aug; 30(8):1103-1108. PubMed ID: 32571446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of combined detection of N-terminal pro-B-type natriuretic peptide and left ventricular ejection fraction in heart function in patients with acute CO poisoning.
    Liu SD; Shen Q; Lv C; Zhang P; Yu H; Yang L; Wu L
    Am J Emerg Med; 2014 Oct; 32(10):1212-4. PubMed ID: 25151325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of NT-ProBNP as an early cardiac marker of carbon monoxide poisoning.
    Davutoglu V; Gunay N; Kocoglu H; Gunay NE; Yildirim C; Cavdar M; Tarakcioglu M
    Inhal Toxicol; 2006 Feb; 18(2):155-8. PubMed ID: 16393930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of global longitudinal strain and plasma natriuretic peptide in patients with asymptomatic left ventricular dysfunction.
    Ulziisaikhan G; Khurelbaatar MU; Khorloo C; Sodovsuren N; Khasag A; Unurjargal T
    Kardiologiia; 2021 Oct; 61(10):53-60. PubMed ID: 34763639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points.
    Luchner A; Hengstenberg C; Löwel H; Buchner S; Schunkert H; Riegger GA; Holmer S
    J Card Fail; 2005 Jun; 11(5 Suppl):S21-7. PubMed ID: 15948096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.
    Islamoglu F; Ozcan K; Apaydin AZ; Soydas C; Bayindir O; Durmaz I
    Tex Heart Inst J; 2008; 35(2):111-8. PubMed ID: 18612440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum N-terminal proBNP, not troponin I, at presentation predicts long-term neurologic outcome in acute charcoal-burning carbon monoxide intoxication.
    Moon JM; Chun BJ; Shin MH; Lee SD
    Clin Toxicol (Phila); 2018 Jun; 56(6):412-420. PubMed ID: 29067847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study.
    Ersbøll M; Valeur N; Mogensen UM; Andersen M; Greibe R; Møller JE; Hassager C; Søgaard P; Køber L
    Eur J Heart Fail; 2012 Oct; 14(10):1121-9. PubMed ID: 22753861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction.
    Islam MN; Chowdhury MS; Paul GK; Debnath RC; Shakil SS
    Mymensingh Med J; 2019 Apr; 28(2):333-346. PubMed ID: 31086148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Cardiotoxic Effects of Carbon Monoxide Poisoning Using Speckle Tracking Echocardiography.
    Saraçoğlu E; Vuruşkan E; Kılıç S; Çekici Y; Onur B; Arslan Y; Kılıç E; Aykut Ö
    Cardiovasc Toxicol; 2018 Apr; 18(2):175-183. PubMed ID: 28986777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function.
    Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW
    Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function.
    Luchner A; Hengstenberg C; Löwel H; Trawinski J; Baumann M; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2002 Jan; 39(1):99-104. PubMed ID: 11799086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
    Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
    Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
    Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
    Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.